Postural stability of normal subjects measured by sway magnetometry: pathlength and area for the age range 15 to 64 years
Abstract
Fifty-eight subjects with no known vestibular pathology, postural problems or cerebrovascular disease were studied to determine the range of sway values in a normal working-age population. Sway was measured with a magnetometry system, previously shown to be highly successful in distinguishing sway with and without the eyes open in individual subjects. 30 subjects were aged 15-29 years and 28 aged 30-64 years. With the subject standing on a firm base the pathlength and area enclosed by movement of the hips in the horizontal plane were measured over 30 second periods with eyes open and eyes closed. There were no significant differences between the two age ranges. We obtained the following upper limits of normal values for the age range 15 to 64 years: pathlength with eyes open 140 mm, pathlength with eyes closed 200 mm, area with eyes open 150 mm2, and area with eyes closed 300 mm2. The mean and standard deviation of the Romberg coefficient (sway with eyes open/sway with eyes closed) was 0.73 +/- 0.09 for pathlength measurement and 0.70 +/- 0.26 for area measurement.
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 30 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.